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Forced swimming testWehave recently shown that the ethanol extract of the leaves ofHedyosmumbrasiliense exhibits an antidepressant-
like effect in the tail suspension and forced swimming tests inmice. The present study investigates themechanisms
involved in the antidepressant-like effect of H. brasiliense extract, together with the antidepressant potential of
podoandin, an isolated sesquiterpenoid. H. brasiliense (50 mg/kg, i.p.) and podoandin (10 mg/kg, i.p.) decreased
the immobility time in the forced swimming test, without any accompanying changes in ambulation in the
open-ﬁeld test. The anti-immobility effect of the H. brasiliense extract was prevented by pre-treating the mice
with ondansetron, NAN 190, pindolol, prazosin, yohimbine, haloperidol, SCH23390, and sulpiride. On the other
hand, pre-treating the mice with: p-chlorophenylalanine (4 consecutive days), ketanserin, naloxone, naltrindole,
bicuculline, phaclofen, or L-arginine did not block the antidepressant-like effect of H. brasiliense. In addition, pre-
treatment of the animals with methylene blue, NG-nitro-L-arginine or 7-nitroindazole, at subeffective doses, did
not cause a synergistic effect with H. brasiliense extract at an effective dose in the forced swimming test. The anti-
immobility effect of podoandinwas also prevented by pre-treating themicewith NAN-190, ondansetron, prazosin,
yohimbine, sulpiride and haloperidol. The results indicate that the antidepressant-like effect of H. brasiliense (and
podoandin) is dependent on the serotonergic, noradrenergic and dopaminergic systems, but not on the GABAergic,
opioid and oxidonitrergic systems.
© 2011 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
After about ﬁfty years of the discovery of the ﬁrst antidepressant
(Castrén, 2005), depression, which is a chronic, relapsing and poten-
tially fatal disease, appears to be increasing. It currently affects about
20% of the population worldwide, and is considered one of the ten
leading causes of morbidity and mortality. It is estimated that by
the year 2020, depression will be the 2nd largest contributor to the
global burden of disease (WHO, 2011a,b). Numerous antidepressant
compounds are now available, which presumably act via different
mechanisms, including the serotonergic, noradrenergic and/or dopa-
minergic systems. The therapies available for treating this disease,
including tricyclic antidepressants, monoamine oxidase inhibitors, and
serotonin reuptake inhibitors, are often associated with various unde-
sirable side effects, and their efﬁcacy beneﬁts only certain parts of the
world's population (Berton and Nestler, 2006). Moreover, most thera-
pies require several weeks of treatment before any improvement inUruguai, 458, CP 360, 88302-
fax: +55 47 3341 7600.
.
sevier OA license.the signs and symptoms is observed. Despite the advances in drug dis-
covery, and the therapeutic options available, there are still many short-
comings that need to be remedied. Medical plant therapies may be
effective alternatives for the treatment of depression. Research in this
area has progressed signiﬁcantly in the past decade (Machado et al.,
2007;WHO, 2011a,b) and this has led to the search for new alternatives
for the treatment of depression (Buller and Legrand, 2001).
Hedyosmum brasiliense is an aromatic shrub, commonly known as
Cidrão, which belongs to the largest genus of the Chloranthaceae
family and is endemic to Brazil. The genus consists of 46 species found
in tropical and subtropical regions of America (Souza and Lorenzi,
2005). Although widely used as a calmative, hypnotic, antidepressant,
stomachic, and aphrodisiac, to treat migraine, and for diseases of the
ovaries (Reitz, 1965), studies attempting to validate the pharmacologi-
cal effects are limited. Only its antinociceptive effect (Trentin et al.,
1999) has been determined previously to our series of investigations,
which includes analysis of its essential oil composition and antimi-
crobial activity (Kirchner et al., 2010), the neurochemical properties
of the ethanol extract, fractions and the antidepressant effect of
isolated sesquiterpene lactones (onoseriolide or 13-hydroxy-8,9-
dehydroshizukanolide and podoandin, 1) which were assessed by
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time, forced swimming, strychnine and pentylenetetrazole-induced
seizure and inhibitory avoidance tests (Tolardo et al., 2010). In the
latter, an antidepressant effect was only observed for the sesqui-
terpenolide podoandin, which exhibited a signiﬁcant reduction in
immobility time. Continuing this research, this paper proposes a
mechanistic investigation of the antidepressant effect of the extract, as
well as that of podoandin which is an isolated sesquiterpene lactone of
the guaianolide type. Some recently investigated guaianolides showed
antiprotozoal (Maas et al., 2011; Sun et al., 2010), analgesic and sedative
(Wesolowska et al., 2006) and cytotoxic (Bruno et al., 2005) effects.
2. Materials and methods
2.1. Extract and compound isolation
Aerial parts of H. brasiliense Miq. Chloranthaceae were collected in
October of 2009 in Antônio Carlos, Santa Catarina State, Brazil. Voucher
specimens were analyzed by the botanist Dr. Ademir Reis, and de-
posited at the Lyman Bradford Smith Herbarium (UNIVALI, Itajaí —
SC) (number 2031). Five kilograms of fresh leaves of H. brasiliense
was blended with bi-distilled alcohol and macerated for 15 days.
The extract obtained was then concentrated in a rotary evaporator.
The recovered ethanol was used to re-macerate the plant, and the
combined concentrated extracts were kept in a desiccator under
vacuum to remove residual solvent, yielding 200 g of crude extract,
of which an aliquot, named extract of H. brasiliense, was used for the
pharmacological tests. To isolate the sesquiterpene lactone podoan-
din, the rest of the extract was then diluted in water and partitioned
with solvents of increasing polarity, yielding the following fractions:
hexane (16 g), dichloromethane (4 g), ethyl acetate (13 g) and a re-
sidual aqueous fraction, which was kept in the freezer. The hexane
fraction was then subjected to ﬂash column chromatography with
silica gel CC (230–400 mesh) using n-hexane with increasing con-
centrations of CH2Cl2 (0–70%) and subsequently using CH2Cl2 with
increasing concentrations of EtOAc (0–70%), (200 ml for each con-
centration), which yielded sub-fractions A to H. Re-crystallization
of sub-fraction B led to the isolation of the guaianolide podoandin
(Fig. 1, 300 mg) with a spectral purity grade identiﬁed by Nuclear
Magnetic Resonance (NMR) spectra in comparison with previously
published data (Blay et al., 2000).
2.2. Animals
Male Swiss mice at 8 weeks of age, weighing 23–30 g were main-
tained at constant room temperature (22–27 °C) with free access to
water and food, under a 12:12 h light–dark cycle (lights on at 07:00 h).
The mice were allowed to acclimatize to the holding room for 24 h be-
fore thebehavioral procedure. All experimentswere carried out between
13:00 and 17:00 h, and each animal was used only once (n=8–10 ani-
mals per group). All the experiments were conducted blind in terms of
the treatment condition of the animals. The USA National Institute of
Health Guidelines for Animal Care and Use were followed, and the ex-
periments were approved by the Animal Care and Ethical Committees
of the University do Vale do Itajaí, under number 007/10. Each animalFig. 1. Structure of podoandin (1), isolated from H. brasiliense.was used only once. All efforts were made to minimize animal suffering
and reduce the number of animals used in the experiments.
2.3. Drugs and treatment
The following drugs were used: L-arginine, methylene Blue, 7-
nitroindazole, NG-nitro-L-arginine, parachlorophenylalanine (PCPA),
ketanserin, Nan 190 (1-(2-Methoxyphenyl)-4-[4-(2-phthalimido)
butyl]piperazine hydrobromide), SCH 23390 (R(+)-7-Chloro-8-
hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine
hydrochloride), prazosin, phaclofen, bicuculline, yohimbine, halo-
peridol, pimozide, naloxone, naltrindole and pindolol, all provided
by Sigma Chemicals (St. Louis, MO, USA). Ondansetronwas provided by
Cristália (Brazil).The extract of H. brasiliense and podoandin was dis-
solved in saline with 10% Tween 80, and all the other drugs were
dissolved in isotonic saline solution (NaCl 0.9%) immediately be-
fore use. All the drugs, the podoandin and the H. brasiliense extract
were administered by the intraperitoneal (i.p.) route, at a volume
of 10 ml/kg body weight. The control animals received appropriate
vehicle. Podoandin (Fig. 1), H. brasiliense, or vehicle was adminis-
tered by the intraperitoneal route 30 min before the forced swim-
ming test or the open-ﬁeld test.
The doses of drugs usedwere selected on the basis of experiments
previously performed in our laboratory and on the literature data
previously reported as not affecting locomotor activity (Jesse et al.,
2010; O'Neill and Conway, 2001; Tolardo et al., 2010; Zomkowski
et al., 2004).
2.4. Forced swimming test (FST)
The test was conducted using the method of Porsolt et al. (1977)
with some modiﬁcations. Mice were individually forced to swim in
an open plexiglass cylinder (diameter 10 cm, height 25 cm), contain-
ing 19 cm of water at 25±1 °C, and the total immobility time during
a 6 min test was scored live (Brocardo et al., 2008; Rosa et al., 2008;
Tolardo et al., 2010; Zomkowski et al., 2004). As reported, classical an-
tidepressants decreased immobility time in this paradigm (Brocardo et
al., 2008; Dhir and Kulkarni, 2007; Kaster et al., 2007; Rosa et al., 2008;
Yamada et al., 2004). Each animal was judged to be immobile when it
stopped struggling and remained ﬂoating or motionless in the water,
making only the movements necessary to keep its head above water.
The absence of hind legmovementwas recorded as immobility by stop-
watch accumulation by a single observer during the exposures.
2.5. Mechanisms involved in the antidepressant-like effect of H. brasiliense
extract and podoandin
To address some of the mechanisms by which H. brasiliense extract
or podoandin causes antidepressant-like action in the forced swim-
ming test, animals were pretreated with different pharmacological
agents.
In order to investigate the possible contribution of the seroto-
nergic system to the anti-immobility effect of H. brasiliense extract
or podoandin in the forced swimming test, animals were pretreated
with PCPA (100 mg/kg, a serotonin synthesis inhibitor) or saline,
once a day, for 4 consecutive days. In previous studies, this treat-
ment regimen of PCPA produced around 60–90% depletion of brain
serotonin concentration in rats (Redrobe et al., 1998; Wang et al.,
2008). The animals received treatment with H. brasiliense extract
(50 mg/kg, i.p.), podoandin (10 mg/kg, i.p.) or vehicle 24 h after the
last PCPA or saline injection, and were tested in the forced swimming
test 30 min later. In separate experiments, animals were pretreated
with ondansetron (a 5HT3 selective receptor antagonist, 0.3 mg/kg),
NAN 190 a 5-HT1A selective receptor antagonist (0.5 mg/kg, i.p.), ketan-
serin a 5-HT2A receptor antagonist, (5 mg/kg, i.p.), pindolol a 5-HT1A/1B
receptor antagonist (10 mg/kg, i.p.) or vehicle, 15 min before the
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the forced swimming test 45 min later.
We investigated the possible involvement of the noradrenergic sys-
tem in the antidepressant-like effect of H. brasiliense extract or podoan-
din in the forced swimming test. Thus, animals were pretreated with
prazosin (1 mg/kg, i.p., an α1-adrenoceptor antagonist), yohimbine
(1 mg/kg, i.p., anα2-adrenoceptor antagonist), or vehicle 15 min before
administration of H. brasiliense extract, podoandin (10 mg/kg, i.p.), and
were tested in the forced swimming test 45 min later.
In order to investigate the inﬂuence of the dopaminergic system on
the antidepressant-like effect of the H. brasiliense extract and podoan-
din, animals were pretreated with haloperidol (0.2 mg/kg, i.p., a nonse-
lective dopaminergic receptor antagonist), SCH23390 (0.05 mg/kg, s.c.,
a dopamine D1 receptor antagonist), sulpiride (50 mg/kg, i.p., a dopa-
mine D2 receptor antagonist), or vehicle, 15 min before administration
of H. brasiliense extract or podoandin (10 mg/kg, i.p.), and then tested
in the forced swimming test 45 min later.
To investigate whether the antidepressant-like effect of H. brasi-
liense extract or podoandin is mediated through the involvement of
the L-arginine-nitric oxide pathway in the forced swimming test, mice
were pretreated with L-arginine, a precursor of nitric oxide
(750 mg/kg, i.p., a dose that produces no effect in the forced swimming
test) or vehicle, 15 min before administration of H. brasiliense extract or
podoandin (10 mg/kg, i.p.), and were tested in the forced swimming
test 45 min later. The dose of L-arginine was chosen based on a previ-
ously reported dose–response curve in the forced swimming test
(Da Silva et al., 2000). In another experiment, we also investigated the
effect of H. brasiliense extract (5 mg/kg, a sub-effective dose) with
sub-effective doses of 7-nitroindazole (50 mg/kg, i.p., a speciﬁc neuro-
nal NO synthase inhibitor), methylene blue (20 mg/kg, i.p., an inhibitor
of both NO synthase and soluble guanylate cyclase) or NG-nitro-L-argi-
nine (0.3 mg/kg, i.p., a nitric oxide synthase inhibitor). The doses of 7-
nitroindazole and methylene blue were chosen based on a previous
report (Brocardo et al., 2008) and the dose of NG-nitro-L-arginine
was also based on a previous report (Jesse et al., 2010). H. brasiliense
extract or vehicle was administered 15 min before the drugs, and
15 min afterwards, the animals were tested in the forced swimming
test.
To investigate whether the antidepressant-like effect of H. brasi-
liense extract ismediated through the involvement of the opioid system,
mice were pretreated with naloxone (1 mg/kg, i.p., a nonselective opi-
oid receptor antagonist) or vehicle, 15 min before administration of
H. brasiliense extract, and were tested in the forced swimming test
45 min later. In another experiment, micewere pretreatedwith naltrin-
dole (3 mg/kg, i.p., a selective δ-opioid receptor antagonist) or vehicle,
15 min before administration of H. brasiliense extract, and were tested
in the forced swimming test 45 min later. The doses of naloxone
and naltrindole were chosen based on a previously reported paper
(Brocardo et al., 2008).
In the same model, the possible participation of the GABAergic
system on the antidepressant-like effect of H. brasiliense extract was
investigated. For this purpose, the animals were pretreated with bicu-
culline, a GABAA receptor antagonist (1.0 mg/kg, i.p.), phaclofen, a
GABAB receptor antagonist (2.0 mg/kg, i.p.) or vehicle. After 15 min
they received H. brasiliense extract (50 mg/kg, i.p.), and were tested
in the forced swimming test 45 min later.
2.6. Interaction of H. brasiliense extract and podoandin with ﬂuoxetine in
the mice FST
We also investigated the ability ofH. brasiliense extract and podoan-
din to potentiate the antidepressant-like effect of ﬂuoxetine, a selective
serotonin reuptake inhibitor. For this purpose, animals were pretreated
with a subeffective dose of H. brasiliense extract (5 mg/kg), podoandin
(1 mg/kg), or saline and 20 min later the animals were treated with a
subeffective dose of ﬂuoxetine (20 mg/kg). The dose of ﬂuoxetine waschosen based on a previous report (Ulak et al., 2010). The forced swim-
ming test was carried out 30 min later.
2.7. Open-ﬁeld test
To assess the possible effect of H. brasiliense and podoandin on
exploratory behavior, the animals were submitted to the open-ﬁeld
paradigm as previously described (Capra et al., 2010). Mice were
individually placed in a wooden box (40×60×50 cm) with the ﬂoor
of the arena divided into 12 equal squares. The number of squares
crossed with all paws (crossing) was considered as indicative of loco-
motor activity and the number of rising with the front paws (rearing)
was indicative of exploratory behavior. These behavioral parameters
were recorded over a 6 min period (Capra et al., 2010; Tolardo et al.,
2010).
2.8. Statistical analysis
All experimental results are given as the mean(s)±S.E.M. Statistical
analysis was performed by two-way ANOVA followed by Newman–
Keuls test for post hoc comparison when appropriate. A value of
Pb0.05 was considered to be signiﬁcant.
3. Results
3.1. Involvement of the serotonergic system
The results depicted in Fig. 2A show that pretreatment of mice with
the serotonin 5HT2A receptor antagonist ketanserin (5 mg/kg, i.p.)
when compared to group treated only with extract, was not able to
reverse the anti-immobility effect of H. brasiliense extract (50 mg/kg)
in the forced swimming test [F(3,28)=29.10; P>0.05]. In addition,
Fig. 2B shows that the pre-treatment of mice with the 5-HT synthesis
inhibitor PCPA (100 mg/kg, i.p., once a day for 4 consecutive days)
when compared to group treated only with extract also did not affect
the antidepressant-like effect of H. brasiliense extract (50 mg/kg)
[F(3,28)=12.73; P>0.05]. On the other hand, pre-treatment of mice
with antagonists of serotonin 5HT1A, 5-HT1A/1B, 5-HT3 receptors,
NAN-190 (0.5 mg/kg, i.p.), pindolol (10 mg/kg, i.p.) or ondansetron,
respectively, when compared to group treated only with extract
was able to reverse the anti-immobility effect of H. brasiliense extract
in the forced swimming test (Fig. 2C, D and E, respectively, [F(3, 27)=
46.13; Pb0.01]; [F(3, 28)=15.44; Pb0.01] and [F(3, 29)=107.24;
Pb0.01]).
3.2. Involvement of the noradrenergic system
Fig. 3A and B shows that pretreatment of mice with the α1-
adrenoceptor antagonist prazosin (1 mg/kg, i.p.) and the α2-
adrenoceptor antagonist yohimbine (1 mg/kg, i.p.) when compared
to group treated only with extract was able to reverse the
antidepressant-like effect of H. brasiliense extract (50 mg/kg) in the
forced swimming test [F(3, 28)=45.26; Pb0.01]; [F(3, 29)=9,61;
Pb0.01], respectively.
3.3. Involvement of the dopaminergic system
Fig. 4A shows that the anti-immobility effect of H. brasiliense
extract (50 mg/kg, i.p.) was signiﬁcantly [F(3, 24)=39.98; Pb0.01]
prevented by pre-treatment of mice with haloperidol (0.2 mg/kg,
i.p.). Similarly, sulpiride (50 mg/kg, i.p.) and SCH23390
(0.05 mg/kg, s.c.) administrations (Fig. 4B and C) were also able
to reverse the antidepressant-like effect of H. brasiliense extract in
the forced swimming test ([F(3, 22)=20.71; Pb0.01]; [F(3, 23)=14,74;
Pb0.05], respectively).
Fig. 2. Effect of pre-treatment of ketanserin (5 mg/kg, i.p., a 5-HT2A/2C receptor antagonist,
panel A), PCPA (5-HT synthesis inhibitors, 100 mg/kg, i.p., for 4 consecutive days, panel B),
NAN-190 (0.5 mg/kg, i.p. a 5-HT1A receptor antagonist, panel C), pindolol (10 mg/kg, i.p., a
5-HT1A/1B receptor antagonist, panel D) or ondansetron (0.3 mg/kg, i.p., a 5HT3 selective
receptor antagonist, panel E) on H. brasiliense extract (50 mg/kg, i.p) induced a decrease
in immobility time in the forced swimming test. All values are presented as mean±S.E.M.
(n=8–10). ***Pb0.001 compared with the control group; ##Pb0.01 or ###Pb0.001 com-
pared with the same group pre-treated with only H. brasiliense extract.
Fig. 3. Effect of pre-treatment of mice with prazosin (1 mg/kg, i.p., an α1-adrenoceptor
antagonist, panel A) or yohimbine (1 mg/kg, i.p., an α2-adrenoceptor antagonist, panel
B) on H. brasiliense extract (50 mg/kg, i.p)-induced reduction in immobility time in the
forced swimming test. Values are expressed as mean±S.E.M. (n=8–10). *Pb0.05,
***Pb0.001, compared with the control group; #Pb0.05 or ###Pb0.001 compared
with the same group pre-treated with only H. brasiliense extract.
Fig. 4. Effect of pre-treatment of mice with haloperidol (0.2 mg/kg, i.p., a non-selective
dopaminergic receptor antagonist, panel A), sulpiride (50 mg/kg, i.p., a dopamine D2
receptor antagonist, panel B) or SCH23390 (0.05 mg/kg, s.c., a dopamine D1 receptor
antagonist, panel C) on H. brasiliense extract (50 mg/kg, i.p)-induced reduction in im-
mobility time in the forced swimming test. Values are expressed as mean±S.E.M.
(n=8–10). **Pb0.01 compared with the control group (vehicle); #Pb0.05, ##Pb0.01
or, compared with the group pretreated with the same group pre-treated with only
H. brasiliense extract.
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monophosphate systems
Concerning the involvement of the L-arginine–nitric oxide–cyclic
guanosine monophosphate systems on the anti-immobility effect of
the extract, the results demonstrated that pre-treatment of mice with
L-arginine (750 mg/kg, i.p., a nitric oxide precursor) did not reverse
the anti-immobility effect elicited by H. brasiliense extract (50 mg/kg,
i.p.) in the forced swimming test [F(3, 18)=26.45; Pb0.01] (Fig. 5A).The results also show that the administration of NG-nitro-L-arginine
(a nitric oxide synthase inhibitor, 0.3 mg/kg i.p., a subeffective dose),
7-nitroindazole (25 mg/kg i.p., a speciﬁc neuronal nitric oxide synthase
Fig. 5. Effect of pre-treatment of mice with L-arginine (750 mg/kg, i.p., panel A) on
H. brasiliense extract (50 mg/kg, i.p)-induced reduction in immobility time in the
forced swimming test. The potentiating effect of (B) NG-nitro-L-arginine (0.3 mg/kg,
i.p.), (C) 7-nitroindazole (25 mg/kg, i.p.) and (D) methylene blue (10 mg/kg, i.p.) on
the action of brasiliense extract (10 mg/kg, i.p) i.p. in the forced swimming test. Values
are expressed as mean±S.E.M. (n=8–10) mice/group. **Pb0.01 compared with the
control group (vehicle).
Fig. 6. Effect of pre-treatment of mice with naloxone (1 mg/kg, i.p., a non selective
opioid receptor antagonist, panel A) and naltrindole (3 mg/kg, i.p., panel B), on the
anti-immobility effect of H. brasiliense extract (50 mg/kg, i.p) in the forced swimming
test. Values are expressed as mean±S.E.M. (n=8–10). **Pb0.01 compared with the
vehicle-treated control.
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inhibitor of both nitric oxide synthase and soluble guanylate cy-
clase), in combination with H. brasiliense extract (5.0 mg/kg, i.p.,
subeffective dose), did not produce an antidepressant-like effect in
forced swimming test [F3, 20=0.29; P>0.05]; [F(3, 20)=1.72; P>0.05];
[F(3, 20)=0.31; P>0.05], respectively, when compared to the adminis-
tration of each drug alone (Fig. 5B, C and D).3.5. Involvement opioid system
Our results also show that pre-treatment of animals with nalox-
one (1 mg/kg, i.p), a nonselective opioid receptor antagonist or nal-
trindole (3 mg/kg, i.p., a selective δ-opioid receptor antagonist) did
not prevent the antidepressant-like effect of H. brasiliense extract
(5.0 mg/kg, i.p.) in the forced swimming test [F(3, 22)=9.05; P>0.05];
[F(3, 22)=30.94; P>0.05], respectively (Fig. 6A and B).3.6. Involvement GABAergic system
The antidepressant effect of H. brasiliense extract appears not to
involve the GABAergic system. Our results also showed that pre-
treatment of animals with bicuculline, a GABAA receptor antagonist
(1.0 mg/kg, i.p.) or phaclofen, a GABAB receptor antagonist (2.0 mg/
kg, i.p.) also failed to prevent the antidepressant-like effect of H. bra-
siliense extract (5.0 mg/kg, i.p.) in the forced swimming test [F(3, 24)=
3.87; P>0.05]; [F(3, 25)=5.82; P>0.05], respectively (Fig. 7A and B).
3.7. Involvement of systems in the mechanism of action of the antide-
pressant property of podoandin
Since the mechanism of action of the anti-immobility effect of
the extract appears to be mediated by the serotonergic, noradrener-
gic and dopaminergic systems, the anti-immobility effect of podoan-
din was also evaluated in these three systems. The results shown in
Table 1 demonstrate that the anti-immobility effect of the compound
in study is reversed by pre-treatment of animals with NAN-190, ondan-
setron, prazosin, yohimbine, sulpiride and haloperidol. However, pre-
treatment of animals with SCH23390 and pindolol was unable to
reverse this effect.
3.8. Interaction of H. brasiliense extract and podoandin with ﬂuoxetine in
the mice forced swimming test
In Fig. 8, it is observed that treatment of animals with podoandin or
H. brasiliense extract, or ﬂuoxetine, in subeffective doses (1.0 mg/kg,
5.0 mg/kg and 20 mg/kg respectively) does not alter the immobility
time in the forced swimming test compared with their respective con-
trols. However, treatment with podoandin and H. brasiliense extract
(in subeffective doses of 1.0 mg/kg and 5.0 mg/kg, respectively), given
in combination with a subeffective dose of ﬂuoxetine (20 mg/kg), sig-
niﬁcantly reduced the immobility time in the forced swimming test
[F(5, 34)=15.71; Pb0.01].
3.9. Effects of drugs on locomotor activity
Since antidepressant-like effects in the forced swimming test can
also be evoked by drugs that induce hyperactivity, the effect of
podoandin (10 mg/kg, i.p.) and H. brasiliense extract (50 mg/kg, i.p)
Fig. 7. Effect of pre-treatment of mice with bicuculline (1.0 mg/kg, i.p., an antagonist of
GABAA receptor, panel A) and phaclofen, (2.0 mg/kg, i.p., an antagonist of GABAB recep-
tor, panel B) on the anti-immobility effect of H. brasiliense extract (50 mg/kg, i.p) in the
forced swimming test. Values are expressed as mean±S.E.M. (n=8–10). *Pb0.05,
compared with the vehicle-treated control.
Fig. 8. Effect of co-administration of the subeffective doses of H. brasiliense extract
(10 mg/kg), podoandin (1.0 mg/kg), and ﬂuoxetine (20 mg/kg) on immobilization
time in forced swimming test in mice. Values are expressed as mean±S.E.M.
(n=8–10). **Pb0.01, compared with the vehicle-treated control.
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with H. brasiliense extract or podoandin, given 30 min beforehand,
did not affect the locomotor activity in the open-ﬁeld test when com-
pared with mice that received vehicle (results not shown).
4. Discussion
The present study contributes to the understanding of the mecha-
nisms underlying the effects of ethanol extract of H. brasiliense in the
forced swimming test. We provide convincing evidence that this
effect is dependent on an interaction with the serotonergic, norad-
renergic and dopaminergic systems. In addition, our results alsoTable 1
Summary of the effects of the various drugs on the anti-immobility effect caused by
podoandin assessed in the forced swimming test.
Treatment Dose (mg/kg) Immobility time
Control 0 120.14±8.28
Prazosin 1.0 114.4±4.1
Yohimbine 1.0 168.7±5.63
Podoandin 10.0 42.28±4.5c
Podoandin+yohimbine 10.0/1.0 91.42±6.22b,f
Podoandin+prazosin 10.0/1.0 85.4±10.50b,e
Control 0 173.37±6.92
NAN-190 0.5 168.85±10.2
Ondansetron 0.3 136.42±21.0
Pindolol 10.0 151.14±11.03
Podoandin 10.0 41.28±4.21c
Podoandin+NAN190 10.0/0.5 85.16±3.19b,d
Podoandin+ondansetron 10.0/0.3 81.10±10.69b,d
Podoandin+pindolol 10.0/10.0 40.40±4.71c,NS
Control 0 104.62±14.03
Haloperidol 0.2 115.33±15.71
Sulpiride 50.0 106.28±15.54
SCH23390 0.05 109.33±18.15
Podoandin 50.0 38.40±4.1c
Podoandin+haloperidol 10.0/0.2 156.66±13.48a,f
Podoandin+sulpiride 10.0/50.0 105.28±5.27e
Podoandin+SCH23390 10.0/0.05 42.85±3.16c,NS
NS, not signiﬁcant compared with podoandin values without the antagonist in each
experiment.
aPb0.05; bPb0.01; cPb0.001, compared with respective controls podoandin values.
dPb0.05; ePb0.01; fPb0.001, compared with podoandin values without the antagonist
in each experiment.demonstrated that the reduction in immobility time in the forced
swimming test elicited by H. brasiliense extract and podoandin was
not accompanied by changes in the locomotor activity assessed in the
open-ﬁeld test, which means that the anti-immobility effect observed
in the forced swimming test cannot be attributable to a psychostimu-
lant activity. Taking into account that psychostimulant drugs may give
a false positive result in animal models of depression, such as the tail
suspension test (Mitchell and Redfern, 2005), our results demonstrate
that the antidepressant-like effect of ethanol extract or podoandin is
speciﬁc.
Currently, the most effective treatment for major depression is con-
sidered to involve an increase in serotonin and/or noradrenaline neuro-
transmission (Brunello et al., 2002). However, studies have shown that
other neurotransmitter systems such as the GABAergic (Uppal et al.,
2010), glutamatergic (Lin et al., 2011), opioid (Schreiber et al., 2002)
and oxidonitrergic (Krass et al., 2011) systems may also be involved
in the pathogenesis of this disease.
As previously reported, PCPA is an inhibitor of the enzyme trypto-
phan hydroxylase, and its administration for four consecutive days de-
pletes the endogenous stores of serotonin by around 60–90% in mice
(Redrobe et al., 1998; Wang et al., 2008). Our results show that a de-
crease in serotonin levels in the synapse did not play a critical role in
the effect of H brasiliense extract, since the anti-immobility effect was
not reversed by pre-treatment with PCPA.
Recent studies have revealed new insights into the therapeutic
role of the 5-HT1A receptors in the treatment of various CNS disorders,
including not only depressive disorders (Prieto et al., 2010), but also
schizophrenia (Yasuno et al., 2004) and Parkinson's disease. The dis-
covery of WAY 100635, the ﬁrst highly selective, potent and silent 5-
HT1 receptor antagonist (Forster et al., 1995), has enabled further
clariﬁcation of the role of 5-HT1A receptors in the antidepressant-
like effects of drugs. It was previously shown that the blockade of
5-HT1A receptors by NAN-190 prevented the antidepressant-like re-
sponses of serotonergic agonists (8-OH-DPAT and buspirone) and
the tricyclic antidepressant desipramine in the forced swimming
test in rats (Detke et al., 1995). Here, we showed the involvement
of 5-HT1A receptors in the antidepressant-like effect of H. brasiliense
extract, since NAN-190 was able to prevent its anti-immobility effect
in the forced swimming test. This supposition was supported by our
results with pindolol, which is a 5-HT1A/1B receptor antagonist that
is also able to prevent the anti-immobility effect of H. brasiliense
extract in the forced swimming test.
It has been reported that agonist 1-[2,5-dimethoxy-4-iodophenyl]-
2-aminopropane (DOI), a preferential 5-HT2A receptor partial agonist en-
hances the antidepressant-like effect of some compounds (Zomkowski
et al., 2004). Moreover, 5HT2 receptor blockade by ketanserin, a prefer-
ential 5-HT2A receptor antagonist, explains the mechanism of action of
several compounds with proven antidepressant activity (Jesse et al.,
2010). In this study, pre-treatment with ketanserin failed to reverse
the antidepressant-like effect of H. brasiliense extract, which suggests
that the antidepressant-like effect of H. brasiliense extract in the forced
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receptors.
Our results are in agreement with the hypothesis that activation of
the 5-HT3 receptors can produce antidepressant-like responses, since
the antidepressant-like effect of H. brasiliense extract was prevented
by the pretreatment of mice with the 5-HT3 antagonist ondansetron.
The involvement of 5-HT3 receptors in the mechanism of action of
antidepressants has been indicated by the fact that different classes
of antidepressants act as functional antagonists of these receptors
(Eisensamer et al., 2003). However, there is evidence that electrocon-
vulsive therapy is able to potentiate the function of 5-HT3 receptors in
the hippocampus (Ishihara and Sasa, 2001).
Several clinical and pre-clinical studies have shown a link between
depression and catecholamines, especially noradrenaline. This is largely
true becausemany of the ﬁrst generation antidepressants, such as tricy-
clics, increase synaptic concentrations of noradrenaline (Moret and
Briley, 2011). In our study, the α1-adrenoceptor antagonist prazosin
and the α2-adrenoceptor antagonist yohimbine were able to reverse
the antidepressant-like effect of H. brasiliense extract in the forced
swimming test, suggesting the involvement of the adrenergic system
in this effect.
Since dopamine is the main neurotransmitter involved in the
mesolimbic reward pathways, it has been proposed that an increase
in dopaminergic neurotransmissionmight counteract anhedonia, which
is considered a core feature of major depressive disorder (Gorwood,
2008). In addition, electroconvulsive therapy used to treat depressive
states that are resistant to the usual antidepressant drugs is considered
one of the most effective therapies for depression, and has beneﬁcial
motor effects in parkinsonian patients (Landau et al., 2011).
Our results showed that the dopaminergic system is clearly involved
in the antidepressant-like action of H. brasiliense extract, since pre-
treatment of animals with haloperidol, SCH23390 and sulpiride, pre-
vented the antidepressant-like effect evoked by the extract. The dopa-
mine D1 and D2 receptors are involved in the anti-immobility action
of antidepressants in the mouse forced swimming test. Yamada et al.
(2004) showed that the dopamine D1 selective antagonist SCH23390,
and the selective D2 antagonist sulpiride, prevented the antidepressant-
like effect of two dopamine reuptake inhibitors, bupropion and
nomifensine, in the forced swimming test.
Many GABAergic effects are mediated via ionotropic GABAA recep-
tors, which are functionally deﬁned by their α subunit (α1–α6), al-
though it remains unknown which speciﬁc GABAA receptor population
mediates the depressant-like effects. Clinical and post-mortem studies
reveal changes in GABAergic transmission localized in the cortical
depression network (Ghose et al., 2011). However, our results show
that the GABAergic system did not participate in the antidepressant-
like action of H. brasiliense extract, since pretreatment of animals with
bicuculline, or phaclofen, did not prevent the antidepressant-like effect
of H. brasiliense extract.
Preclinical studies have also indicated that antidepressant-like
effects in the forced swimming test are produced by the adminis-
tration of μ and δ-opioid receptor agonists (Villard et al., 2011).
Furthermore, clinical trials indicate that opioid compounds such
as beta-endorphin and buprenorphine have antidepressant effects
(Dinas et al., 2011) and eletroconvulsive therapy and acupuncture
increase the plasma levels of beta-endorphin, indicating that the
treatment of refractory depression may be also mediated by opioid
peptides (Ghadirian et al., 1988). In the present study, we show
that pretreatment with naloxone, or naltrindole, failed to reverse
the antidepressant-like effect elicited by H. brasiliense extract, indi-
cating that its effect is not mediated by an interaction with the opi-
oid system.
Nitric oxide modulates norepinephrine (O'Sullivan et al., 2009),
serotonin (Ulak et al., 2008), dopamine (Dhir and Kulkarni, 2007) and
glutamate (Boix et al., 2011) which are the main neurotransmitters
involved in the neurobiology of major depression. Clinical studieshave also conﬁrmed the nitric oxide modulatory activity of various
antidepressants, particularly selective serotonin reuptake inhibitors
(Crespi, 2010). Further support for the hypothesis that the inhibition
of nitric oxide synthase, with a subsequent decrease in the concen-
tration of cyclic guanosinemonophosphate (Snyder, 1992), may pro-
duce antidepressant-like effects, at least under certain conditions, is
the reported reduction in immobility time in the forced swimming
test elicited either by the administration of methylene blue, which
acts as a direct inhibitor of both nitric oxide synthase and soluble
guanylate cyclase (Jesse et al., 2010), or by the speciﬁc inhibitor of
soluble guanylate cyclase activity, 1H-(1,2,4)-oxodiazolo (4,3-a)
quinoxalin-1-one (Ergün and Ergün, 2007). In this study, we show
that pre-treatment of mice with L-arginine did not produce any ef-
fect in the forced swimming test, and therefore did not inhibit the
anti-immobility effect caused by H. brasiliense extract. Furthermore,
a synergistic antidepressant-like effect was not observed when
H. brasiliense extract was administered with NG-nitro-L-arginine,
7-nitroindazole or methylene blue, indicating that the antidepressant-
like effect of H. brasiliense extract does not involve the oxidonitrergic
system.
Another ﬁnding of this study was that the classical antidepressant
ﬂuoxetine was able to potentiate the action of subeffective doses of
H. brasiliense extract in the forced swimming test. This result suggests
that the effect of this extract is similar to the effect of ﬂuoxetine with
regard to the interaction with the 5-HT receptor subtypes.
Concerning the chemical constituents of H. brasiliense extract
used in our experiments, classical phytochemical methods indicated
sesquiterpenolides and simple phenolics as the main constituents
(unpublished data). Sesquiterpenolides represent a very large group
of secondary metabolites, which are very diverse in terms of their
chemical structures and biological activity. Themajority of sesquiterpe-
nolides exert their biological activity by interfering in the function of
the cellular macromolecules, through the formation of covalent bonds
between the electrophilic partial structures of the sesquiterpenolide
and the nucleophilic centers of the biological targets. A signiﬁcant pro-
portion of these molecules show strong activity on the neural systems,
particularly neuroprotective activities (Chung et al., 2010), and these
compounds can act as pharmacological targets for neurodegenerative
diseases like Parkinson's and Alzheimer's. This study demonstrates
that podoandin exhibits an antidepressant-like effect similar to that
of H. brasiliense extract, and that this antidepressant-like effect was
reverted by treating the animals with NAN-190, ondansetron, prazosin,
yohimbine, sulpiride and haloperidol, but not with SCH23390 and
pindolol. This suggests that this compound may also be responsible
for the antidepressant-like effect of H. brasiliense extract, which
seems to be mediated by interaction with the noradrenergic, dopa-
minergic and serotonergic systems, but not with the GABAergic, opi-
oid and oxidonitrergic systems.Acknowledgments
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